Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Hoffgaard

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Proteomics|March 6, 2018
Translating Immunopeptidomics to Immunotherapy-Decision-Making for Patient and Personalized Target SelectionJens Fritsche, Barbara Rakitsch, Franziska Hoffgaard, et al.
Nature Communications|September 27, 2018
RNA editing derived epitopes function as cancer antigens to elicit immune responsesMinying Zhang, Jens Fritsche, Jason Roszik, et al.
Journal of Medicinal Chemistry|August 15, 2015
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design ApproachJulian Engel, André Richters, Matthäus Getlik, et al.
Science Translational Medicine|August 31, 2022
Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapyGloria B Kim, Jens Fritsche, Sebastian Bunk, et al.
Cancer Immunology Research|May 12, 2023
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic CancerApostolia M Tsimberidou, Kerstin Guenther, Borje S Andersson, et al.
Nature|December 21, 2018
Actively personalized vaccination trial for newly diagnosed glioblastomaNorbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, et al.
Nature|February 9, 2019
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastomaNorbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, et al.
Journal of Cheminformatics|December 23, 2017
11th German Conference on Chemoinformatics (GCC 2015) : Fulda, Germany. 8-10 November 2015Uli Fechner, Chris de Graaf, Andrew E Torda, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Proteomics|March 6, 2018
Translating Immunopeptidomics to Immunotherapy-Decision-Making for Patient and Personalized Target SelectionJens Fritsche, Barbara Rakitsch, Franziska Hoffgaard, et al.
Nature Communications|September 27, 2018
RNA editing derived epitopes function as cancer antigens to elicit immune responsesMinying Zhang, Jens Fritsche, Jason Roszik, et al.
Journal of Medicinal Chemistry|August 15, 2015
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design ApproachJulian Engel, André Richters, Matthäus Getlik, et al.
Science Translational Medicine|August 31, 2022
Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapyGloria B Kim, Jens Fritsche, Sebastian Bunk, et al.
Cancer Immunology Research|May 12, 2023
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic CancerApostolia M Tsimberidou, Kerstin Guenther, Borje S Andersson, et al.
Nature|December 21, 2018
Actively personalized vaccination trial for newly diagnosed glioblastomaNorbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, et al.
Nature|February 9, 2019
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastomaNorbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, et al.
Journal of Cheminformatics|December 23, 2017
11th German Conference on Chemoinformatics (GCC 2015) : Fulda, Germany. 8-10 November 2015Uli Fechner, Chris de Graaf, Andrew E Torda, et al.
Pageof 2